Biotech grants in the Netherlands
Explore Biotech grants for companies in the Netherlands. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from Dutch innovation agencies, research funders and foundations, EU and international programs open to applicants in the Netherlands, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in the Netherlands come first.
Showing 265-288 of 628 grants
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01)
NIH · United States
Funds new screening tests or treatments for serious newborn conditions — including ones not yet on any screening panel.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21)
NIH · United States
Funds the exploratory version of the same work on screening tests and treatments for serious newborn conditions.
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment
NIH · United States
Funds academic-industry partnerships that turn a lab discovery into a working diagnostic or treatment tool, without a clinical trial attached.
Basic Research in Cancer Health Disparities (R01)
NIH · United States
Funds basic mechanistic research into the biological and genetic causes of cancer health disparities — and into building the tools that research needs.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
NIH · United States
Funds mechanistic work on the lasting harms cancer therapy causes, and on turning that understanding into ways to prevent them.
Exploratory/Developmental Bioengineering Research Grants (EBRG)
NIH · United States
Funds early feasibility work on a new biomedical tool, instrument or method that could improve research, care delivery or accessibility.
Mood and Psychosis Symptoms during the Menopause Transition (R01)
NIH · United States
Funds translational work on the neurobiology behind mood and psychotic symptoms during the menopause transition, aimed at treatment targets.
Mood and Psychosis Symptoms during the Menopause Transition (R21)
NIH · United States
Funds the exploratory version of the same translational work on mood and psychotic symptoms during the menopause transition.
Natural History of Disorders Screenable in the Newborn Period
NIH · United States
Funds studies of how conditions found by newborn screening unfold — the sequence and timing of symptoms, and what changes the course.
NIH Exploratory/Developmental Research Project Grant
NIH · United States
Funds an early-stage, high-risk project that includes a clinical trial — and at some institutes only a mechanistic one counts.
NIH Research Project Grant
NIH · United States
Funds a defined research project in the investigator's own area of expertise, through the announcement most NIH institutes keep permanently open.
NIH Small Research Grant Program
NIH · United States
Funds a small project that can be finished quickly with limited resources — a pilot, a reanalysis, a method, or a piece of new research technology.
Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies
NIH · United States
Funds functional testing of genetic variants linked to congenital anomalies, to separate the ones that matter from the ones that merely appear.
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases
FDA · United States
Funds natural history studies that track how a rare disease unfolds over time, to close data gaps blocking new treatments for it.
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders
NIH · United States
Funds no new studies directly — it grants approved investigators access to NIH's shared genetic and multi-omics data on heart, lung, blood and sleep disorders.
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
FDA · United States
Funds clinical trials testing whether a product works and is safe for a rare disease, aimed at a new indication or a labeling change.
INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research
NIH · United States
Funds planning then running a milestone-driven clinical trial for a health condition that co-occurs with Down syndrome.
INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome
NIH · United States
Funds early, exploratory Down syndrome research — a novel idea or new use of an existing method, even where the answer is unproven.
INCLUDE Project: Transformative Research Awards for Down syndrome
NIH · United States
Funds bold, unconventional Down syndrome research that could open an entirely new scientific or clinical direction.
Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose
NIH · United States
Funds discovering and developing a medication or device to prevent or treat substance use disorders and overdose, in two phases.
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders)
NIH · United States
Funds high-risk, high-reward research on HIV prevention, diagnosis or treatment in people who use substances or have a substance use disorder.
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
NIH · United States
Funds secondary analysis of archived HIV/AIDS data and specimens from maternal, pediatric and adolescent populations, without collecting anything new.
Early Immune System Development and Ontogeny
NIH · United States
Funds research into how the immune system forms in the womb, infancy and early childhood, including under HIV or antiretroviral exposure.
The Metastasis Research Network (MetNet): MetNet Research Projects
NIH · United States
Funds a research project that plugs into NCI's Metastasis Research Network of systems-level cancer centers, up to $500,000.